Compare Stocks: HIT, OPRX, HCAT, and DH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DH Definitive Healthcare	$0.99 +0.4%	$0.89	$0.61 ▼ $3.12	$104.76M	1.4	774,545 shs	90,893 shs
HCAT Health Catalyst	$1.74	$1.73	$0.96 ▼ $3.62	$130.95M	1.54	462,147 shs	458,316 shs
HIT Health In Tech	$0.67 -1.1%	$0.91	$0.63 ▼ $3.54	$43.96M	2.81	235,030 shs	42,600 shs
OPRX OptimizeRx	$8.29 -1.7%	$7.88	$4.54 ▼ $22.25	$158.69M	1.26	185,125 shs	81,218 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DH Definitive Healthcare	+0.41%	+1.56%	-3.39%	+20.00%	-67.48%
HCAT Health Catalyst	0.00%	-1.14%	-4.40%	-23.68%	-40.00%
HIT Health In Tech	-1.06%	-11.78%	-24.58%	-37.31%	-80.83%
OPRX OptimizeRx	-1.66%	-3.04%	+6.15%	+24.66%	-58.34%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DH Definitive Healthcare	$0.99 +0.4%	$0.89	$0.61 ▼ $3.12	$104.76M	1.4	774,545 shs	90,893 shs
HCAT Health Catalyst	$1.74	$1.73	$0.96 ▼ $3.62	$130.95M	1.54	462,147 shs	458,316 shs
HIT Health In Tech	$0.67 -1.1%	$0.91	$0.63 ▼ $3.54	$43.96M	2.81	235,030 shs	42,600 shs
OPRX OptimizeRx	$8.29 -1.7%	$7.88	$4.54 ▼ $22.25	$158.69M	1.26	185,125 shs	81,218 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DH Definitive Healthcare	+0.41%	+1.56%	-3.39%	+20.00%	-67.48%
HCAT Health Catalyst	0.00%	-1.14%	-4.40%	-23.68%	-40.00%
HIT Health In Tech	-1.06%	-11.78%	-24.58%	-37.31%	-80.83%
OPRX OptimizeRx	-1.66%	-3.04%	+6.15%	+24.66%	-58.34%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DH Definitive Healthcare	1.90	Reduce	$1.47	49.32% Upside
HCAT Health Catalyst	2.11	Hold	$2.15	23.56% Upside
HIT Health In Tech	2.67	Moderate Buy	$3.50	421.77% Upside
OPRX OptimizeRx	2.56	Moderate Buy	$11.57	39.58% Upside

Current Analyst Ratings Breakdown

Latest HIT, OPRX, HCAT, and DH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/29/2026	OPRX OptimizeRx	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$10.00 ➝ $11.00
9/25/2026	HIT Health In Tech	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D)
9/4/2026	DH Definitive Healthcare	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral
8/31/2026	DH Definitive Healthcare	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
8/25/2026	OPRX OptimizeRx	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D) ➝ Sell (D+)
8/20/2026	HCAT Health Catalyst	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy ➝ Hold	$3.00 ➝ $1.80
8/14/2026	HIT Health In Tech	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$4.00 ➝ $3.00
8/14/2026	OPRX OptimizeRx	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$11.00
8/14/2026	OPRX OptimizeRx	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Market Outperform
8/14/2026	OPRX OptimizeRx	Citizens Jmp Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Market Outperform	$9.00 ➝ $11.00
8/13/2026	OPRX OptimizeRx	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$12.00

(Data available from 10/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DH Definitive Healthcare	$241.52M	0.44	$1.97 per share	0.50	$2.66 per share	0.37
HCAT Health Catalyst	$311.14M	0.42	$2.12 per share	0.82	$3.47 per share	0.50
HIT Health In Tech	$32.83M	1.34	N/A	N/A	N/A	∞
OPRX OptimizeRx	$98.65M	1.58	$0.97 per share	8.56	$6.88 per share	1.20

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DH Definitive Healthcare	-$138.93M	-$1.60	24.53	24.64	12.11	-72.28%	3.55%	1.63%	11/5/2026 (Estimated)
HCAT Health Catalyst	-$177.97M	-$3.68	N/A	N/A	N/A	-90.61%	-1.83%	-0.80%	11/9/2026 (Estimated)
HIT Health In Tech	N/A	-$0.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	$5.13M	$0.23	36.05	12.56	N/A	4.66%	9.44%	7.11%	11/5/2026 (Estimated)

Latest HIT, OPRX, HCAT, and DH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	HCAT Health Catalyst	-$0.02	N/A	N/A	N/A	$55.38 million	N/A
11/5/2026	Q3 2026	DH Definitive Healthcare	$0.04	N/A	N/A	N/A	$54.57 million	N/A
11/5/2026	Q3 2026	OPRX OptimizeRx	$0.18	N/A	N/A	N/A	$21.19 million	N/A
8/13/2026	Q2 2026	HIT Health In Tech	-$0.03	-$0.04	-$0.01	-$0.04	N/A	$8.06 million
8/12/2026	Q2 2026	OPRX OptimizeRx	$0.1111	$0.16	+$0.0489	-$0.04	$20.20 million	$20.50 million
8/10/2026	Q2 2026	DH Definitive Healthcare	$0.0427	$0.05	+$0.0073	-$0.05	$55.47 million	$55.20 million
8/6/2026	Q2 2026	HCAT Health Catalyst	$0.0299	$0.04	+$0.0101	-$0.55	$69.09 million	$70.49 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DH Definitive Healthcare	N/A	N/A	N/A	N/A	N/A
HCAT Health Catalyst	N/A	N/A	N/A	N/A	N/A
HIT Health In Tech	N/A	N/A	N/A	N/A	N/A
OPRX OptimizeRx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DH Definitive Healthcare	0.81	1.86	1.86
HCAT Health Catalyst	1.51	2.70	2.70
HIT Health In Tech	N/A	N/A	N/A
OPRX OptimizeRx	0.14	5.58	5.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DH Definitive Healthcare	98.67%
HCAT Health Catalyst	85.00%
HIT Health In Tech	N/A
OPRX OptimizeRx	76.47%

Insider Ownership

Company	Insider Ownership
DH Definitive Healthcare	17.09%
HCAT Health Catalyst	19.40%
HIT Health In Tech	77.65%
OPRX OptimizeRx	7.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DH Definitive Healthcare	686	106.75 million	88.50 million	Not Optionable
HCAT Health Catalyst	1,200	75.26 million	60.66 million	Optionable
HIT Health In Tech	91	65.54 million	N/A	N/A
OPRX OptimizeRx	105	18.84 million	17.42 million	Optionable

HIT, OPRX, HCAT, and DH Headlines

Recent News About These Companies

OptimizeRx Corp. (OPRX) - What Are Researchers Thinking About This Stock?

1 hour ago | marketbeat.com

OptimizeRx (NASDAQ:OPRX) & Certara (NASDAQ:CERT) Head to Head Contrast

October 12 at 4:45 AM | americanbankingnews.com

Teladoc Health (NYSE:TDOC) and OptimizeRx (NASDAQ:OPRX) Head-To-Head Contrast

October 8, 2026 | americanbankingnews.com

OptimizeRx CFO Reports Withholding of 414 Shares for RSU Tax Payment

October 4, 2026 | kalkinemedia.comK

OptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. Riley Financial

September 29, 2026 | marketbeat.com

Squarepoint Ops LLC Sells 132,507 Shares of OptimizeRx Corp. $OPRX

September 24, 2026 | marketbeat.com

OptimizeRx Expands Authenticated HCP Reach on The Trade Desk

September 23, 2026 | martechcube.comM

OptimizeRx Corp. And The Trade Desk Bring Net New Authenticated HCP Reach To The Trade Desk Through OpenPath

September 22, 2026 | marketscreener.comM

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath

September 22, 2026 | globenewswire.com

Optimizerx stock edges lower as investors digest recent results

September 20, 2026 | ad-hoc-news.deA

OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Brokerages

September 20, 2026 | marketbeat.com

OptimizeRx stock gains guidance clarity after Q2 2026 results

September 19, 2026 | ad-hoc-news.deA

OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook

September 18, 2026 | seekingalpha.com

Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)

September 16, 2026 | defenseworld.netD

OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence

September 14, 2026 | globenewswire.com

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

September 8, 2026 | globenewswire.com

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

September 2, 2026 | globenewswire.com

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...

August 13, 2026 | uk.finance.yahoo.com

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

August 13, 2026 | finance.yahoo.com

OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition

August 13, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIT, OPRX, HCAT, and DH Company Descriptions

Definitive Healthcare NASDAQ:DH

$0.99 +0.00 (+0.41%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$0.98 0.00 (-0.24%)

As of 04:00 AM Eastern

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Health Catalyst NASDAQ:HCAT

$1.74 0.00 (0.00%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$1.69 -0.05 (-3.10%)

As of 04:01 AM Eastern

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Health In Tech NASDAQ:HIT

$0.67 -0.01 (-1.06%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$0.67 +0.00 (+0.33%)

As of 10/14/2026 07:12 PM Eastern

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

OptimizeRx NASDAQ:OPRX

$8.29 -0.14 (-1.66%)

Closing price 10/14/2026 04:00 PM Eastern

Extended Trading

$8.28 0.00 (-0.06%)

As of 04:29 AM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIT, OPRX, HCAT, and DH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIT, OPRX, HCAT, and DH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIT, OPRX, HCAT, and DH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIT, OPRX, HCAT, and DH Company Descriptions

Definitive Healthcare NASDAQ:DH

Health Catalyst NASDAQ:HCAT

Health In Tech NASDAQ:HIT

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIT, OPRX, HCAT, and DH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIT, OPRX, HCAT, and DH Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIT, OPRX, HCAT, and DH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIT, OPRX, HCAT, and DH Company Descriptions

Definitive Healthcare NASDAQ:DH

Health Catalyst NASDAQ:HCAT

Health In Tech NASDAQ:HIT

OptimizeRx NASDAQ:OPRX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools